CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST), where we discuss what to expect from your time at the bench, share tips, tricks, and information.

All Posts

Our immune system has the ability to detect and fight infectious pathogens. It can also detect when normal cells become cancerous and kill those cells, preventing cancer progression. But over time, cancers can evolve and evade the immune response.

Researchers have been investigating several potential avenues to counter tumor immunosuppression and re-activate the immune system. One of these is CAR-T therapy, which is designed to harness the potent cytotoxicity of T cells by re-engineering their surface receptors to recognize and attack tumors.

Part One:

 

Part Two:

 

Chris Sumner
Chris Sumner
Chris Sumner was the Editor-in-Chief of Lab Expectations. When he's not reading/writing about curing disease, he's hiking in the woods, playing guitar, or searching for the world's best lobster roll.

Recent Posts

Do mRNA and protein levels correlate? Not necessarily.

To what extent does mRNA dictate cellular protein levels? It depends. For decades, scientists have used t...
Tyler Levy Apr 23, 2025

Spatial Insights for CAR-Engineered Cells in Solid Tumors: Antibody-Based CAR Detection Method

Cell Signaling Technology provides products and services are for research use only and not for use in dia...
Amrik Singh, PhD Apr 16, 2025

Watch Your Bax: How a Faulty Antibody May Have Cost Millions in Flawed Research

Science is a collaborative effort—a joint pursuit where each discovery builds on the foundation built by ...
Alexandra Foley Apr 9, 2025